S Iscaki

586 total citations
34 papers, 486 citations indexed

About

S Iscaki is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, S Iscaki has authored 34 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in S Iscaki's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). S Iscaki is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). S Iscaki collaborates with scholars based in France and Belgium. S Iscaki's co-authors include J Pillot, Hakim Hocini, J P Bouvet, René Pirès, Jean Bouvet, Pierre Becquart, Laurent Bélec, Morgane Bomsel, M Raynaud and Jacques Charlemagne and has published in prestigious journals such as Nature, The Journal of Immunology and Infection and Immunity.

In The Last Decade

S Iscaki

32 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Iscaki France 14 252 150 109 92 60 34 486
Canh P. Quan France 11 213 0.8× 116 0.8× 97 0.9× 37 0.4× 70 1.2× 21 419
J W Mannhalter Austria 12 276 1.1× 44 0.3× 93 0.9× 48 0.5× 70 1.2× 25 493
R. MacDonald Australia 9 141 0.6× 70 0.5× 116 1.1× 25 0.3× 168 2.8× 10 467
L Walker United Kingdom 9 251 1.0× 44 0.3× 84 0.8× 114 1.2× 69 1.1× 15 639
R R Rich United States 11 386 1.5× 77 0.5× 81 0.7× 36 0.4× 80 1.3× 17 568
E. Weinmann Germany 13 98 0.4× 41 0.3× 90 0.8× 156 1.7× 192 3.2× 30 513
M W Steward United Kingdom 13 228 0.9× 162 1.1× 155 1.4× 13 0.1× 176 2.9× 17 512
T Lehner United Kingdom 14 209 0.8× 23 0.2× 106 1.0× 111 1.2× 164 2.7× 29 650
C H Aloisio United States 8 105 0.4× 114 0.8× 94 0.9× 121 1.3× 54 0.9× 9 423
P Tabona United Kingdom 12 612 2.4× 58 0.4× 256 2.3× 24 0.3× 113 1.9× 14 887

Countries citing papers authored by S Iscaki

Since Specialization
Citations

This map shows the geographic impact of S Iscaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Iscaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Iscaki more than expected).

Fields of papers citing papers by S Iscaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Iscaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Iscaki. The network helps show where S Iscaki may publish in the future.

Co-authorship network of co-authors of S Iscaki

This figure shows the co-authorship network connecting the top 25 collaborators of S Iscaki. A scholar is included among the top collaborators of S Iscaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Iscaki. S Iscaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hocini, Hakim, et al.. (2000). An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease. Journal of Immunological Methods. 235(1-2). 53–60. 9 indexed citations
2.
Hocini, Hakim, Laurent Bélec, S Iscaki, et al.. (1997). High-Level Ability of Secretory IgA to Block HIV Type 1 Transcytosis: Contrasting Secretory IgA and IgG Responses to Glycoprotein 160. AIDS Research and Human Retroviruses. 13(14). 1179–1185. 75 indexed citations
3.
Bouige, Philippe, S Iscaki, Agata Budkowska, Alain Cosson, & J Pillot. (1997). Interest of immunomodulation as a mean to improve the preparation of polyclonal and monoclonal antibody reagents. Journal of Immunological Methods. 200(1-2). 27–37. 5 indexed citations
4.
Bouige, Philippe, S Iscaki, Alain Cosson, & J Pillot. (1996). Molecular analysis of the modulatory factors of the response to HBsAg in mice as an approach to HBV vaccine enhancement. FEMS Immunology & Medical Microbiology. 13(1). 71–79. 15 indexed citations
5.
Hocini, Hakim, Laurent Bélec, S Iscaki, et al.. (1995). Systemic and Secretory Humoral Immunity in the Normal Human Vaginal Tract. Scandinavian Journal of Immunology. 42(2). 269–274. 50 indexed citations
6.
Bouvet, J P, René Pirès, S Iscaki, & Jean‐Paul Pillot. (1993). Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions.. The Journal of Immunology. 151(5). 2562–2571. 26 indexed citations
7.
Fellah, Julien S., et al.. (1992). Transient Developmental Expression of IgY andSecretory Component like Protein in the Gut of theAxolotl (Ambystoma mexicanum ). Journal of Immunology Research. 2(3). 181–190. 22 indexed citations
8.
Bouvet, Jean, Hakim Hocini, & S Iscaki. (1992). Secretory Component is Bound to the Paraproteins in Sera of IgA and IgM Gammopathies. Scandinavian Journal of Immunology. 35(1). 79–83. 5 indexed citations
9.
Hocini, Hakim, et al.. (1992). Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.. Annals of the Rheumatic Diseases. 51(6). 790–792. 16 indexed citations
10.
Bouvet, J P, René Pirès, Canh P. Quan, S Iscaki, & J Pillot. (1991). Non‐immune VH‐binding Specificity of Human Protein Fv. Scandinavian Journal of Immunology. 33(4). 381–386. 20 indexed citations
11.
Bouvet, J P, J Pillot, & S Iscaki. (1990). Secretory Component‐Binding Properties of Normal Serum IgM. Scandinavian Journal of Immunology. 31(4). 437–441. 4 indexed citations
12.
Kapel, Nathalie, D. Meillet, S Iscaki, et al.. (1990). Characterisation of the main molecular forms of human fecal immunoglobulin A. Clinica Chimica Acta. 195(1-2). 67–75. 4 indexed citations
13.
Iscaki, S, et al.. (1986). Both Fcα domains of human IgA are involved in in vitro interaction between secretory component and dimeric IgA. Immunology Letters. 13(5). 221–226. 24 indexed citations
15.
Iscaki, S, et al.. (1981). [Serum secretory IgA in liver diseases and various other disorders (author's transl)].. PubMed. 5(3). 305–13. 5 indexed citations
16.
Iscaki, S, et al.. (1979). Human secretory component. II. Easy detection of abnormal amounts of combined secretory component in human sera. Journal of Immunological Methods. 28(3-4). 331–339. 10 indexed citations
17.
Iscaki, S, et al.. (1979). [Use of serum s-IgA detection in liver pathology (author's transl)].. PubMed. 27(8). 483–6. 4 indexed citations
18.
Iscaki, S & M Raynaud. (1972). Neutralizing activity of equine anti-diphtheria antibody fragments.. Ann. Inst. Pasteur. 123(5). 695–705. 1 indexed citations
19.
Falcoff, R., et al.. (1972). Lymphocyte stimulation and interferon induction by 7 S anti‐human lymphocyte globulins and their uni‐ and divalent fragments. European Journal of Immunology. 2(5). 476–478. 24 indexed citations
20.
Iscaki, S, et al.. (1966). [The presence of antibody activity in light chain preparations].. PubMed. 263(2). 204–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026